IndulgeRx gets all-A WIPO patent results for IRX FOODSCORE

IndulgeRx Brands said the World Intellectual Property Organization has published three Patent Cooperation Treaty applications for its IRX FOODSCORE platform, each backed by an all-A international search report. The result strengthens the Utah nutrition-tech company’s intellectual property position as it moves toward seed and Series A talks and possible partnerships.

Why it matters: - WIPO’s publication and the all-A search reports give IndulgeRx an independent, government-verified patent record for its AI-powered nutrition platform. - The outcome may strengthen the company’s IP moat ahead of seed round and Series A discussions, plus strategic partnership talks. - The company says the milestone also supports multiple monetizable use cases across consumer apps, licensing, retail, payers and providers, pharmacists, sports performance, research, and government.

What happened: - IndulgeRx Brands said WIPO published all three of its Patent Cooperation Treaty applications on July 23, 2026. - The applications cover IRX FOODSCORE as a software platform, a system, and a business method. - Each application received an all-A International Search Report from the U.S. International Searching Authority. - Each written opinion found the claims novel, inventive, and industrially applicable. - The published application numbers are WO2026156106 A1 for IRX FS SOFTWARE, WO2026156110 A1 for IRX FS METHOD, and WO2026156104 A1 for IRX FS SYSTEM.

The details: - WIPO search reports grade prior art with A, Y, and X citations. - X citations can block patentability. - Y citations can defeat claims through combinations of existing ideas. - IndulgeRx said all three applications produced zero X citations and zero Y citations. - Every cited reference came back as A-level background material. - The examiner concluded that combining prior art to reject the claims would be “impermissible hindsight.” - The examiner also found that any such combination would not add advantages or would require more complexity than ordinary skill. - The patent filings are publicly accessible in WIPO PATENTSCOPE. - The company said the priority date is Jan. 16, 2025. - Patent counsel said one filing needed a minor procedural claim-grouping clarification that did not affect the A grades or novelty findings.

Between the lines: - The result is unusual for a small, self-funded company because global patent scrutiny often produces tougher search outcomes. - The company is using the WIPO record to signal that IRX FOODSCORE is not an incremental add-on but a distinct platform. - The patent win also serves as proof point for investors evaluating whether the business can defend its technology and commercial plans. - The company framed the finding as especially relevant against larger health-tech and software players named in the search process, including Medtronic, Oracle, Salesforce, and Cornell.

What's next: - IndulgeRx says the patent milestone will support upcoming fundraising and partnership conversations. - The company is positioning IRX FOODSCORE for use across consumer, clinical, retail, and institutional channels. - IndulgeRx is directing readers to more information, the IRX FOODSCORE page, and Fight Back Foods.

The bottom line: - IndulgeRx now has three published WIPO patent applications and three all-A search reports backing IRX FOODSCORE, a result the company says materially de-risks its technology story.